Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with noncomplicated or complex Crohn's disease: results from the EVOLVE Expansion study
{{output}}
Background: Real-world effectiveness/safety of vedolizumab and ustekinumab as first-line biologics in Crohn's disease were evaluated by disease complexity. Metho... ...
